How do aspirin's stomach issues differ from newer drugs?

Why are older heart medications like aspirin falling behind newer options?

Aspirin, once hailed as a miracle medicine for heart health, is no longer considered a first-line treatment for many patients. Newer drugs have taken its place, offering improved efficacy and reduced gastrointestinal side effects.

What's behind aspirin's stomach issues?

Aspirin belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). They work by blocking the production of prostaglandins, hormone-like substances responsible for inflammation and pain. However, this blockade also damages the stomach lining, leading to irritation and ulcers [1, Drugpatentwatch.com] www.drugpatentwatch.com.

How do newer heart medications address stomach issues?

Newer heart medications, such as clopidogrel (Plavix) and ticagrelor (Brilinta), are platelet inhibitors that reduce blood clot formation without affecting stomach prostaglandins [2]. These medications are designed to be gentler on the stomach and have fewer gastrointestinal side effects, making them a more viable option for patients with cardiovascular disease.

Can aspirin's legacy be salvaged?

Although aspirin's legacy as a cardiovascular treatment is being eroded by newer medications, it still has a role in certain situations, such as in patients with very low doses or as an adjunct therapy for patients who cannot take statins [3]. Researchers are also exploring ways to minimize aspirin's stomach issues, such as using delayed-release formulations or combining it with stomach-protecting medications.

Sources:

[1] www.drugpatentwatch.com

[2] Journal of Thrombosis and Haemostasis, 2019

[3] Journal of American College of Cardiology, 2020